Speaker List - MarketsandMarkets Precision Medicine Conference

MarketsandMarkets Precision Medicine Conference

22nd - 23rd June 2023 | Boston, USA
CONFERENCE SPEAKERS
Speakers
Shannon Muir
Shannon Muir
Co-director of the California Initiative to Advance Precision Medicine in the California Governor’s Office of Planning and Research,


Shannon Muir is a co-director of the California Initiative to Advance Precision Medicine in the California Governor’s Office of Planning and Research, and leads their work in cancer disparities and precision mental health. Dr. Muir previously served as a director of UC San Diego’s Research Proposal Development Services in the Office of Research Affairs, and as a senior program associate for the California Council on Science and Technology where she coordinated state government affairs for the four Department of Energy and two NASA laboratories located in California. She was previously a science and technology policy fellow in the California Senate Committee on Health. Dr. Muir received a PhD in biomedical sciences from UC San Diego, a master’s degree in pharmacology from Tulane University, and a bachelor’s degree in psychobiology from UCLA.


Schott Cecilia
Schott Cecilia
Global head Precision Medicine Diagnostics Novartis,



Manish Kohli
Manish Kohli
Professor,
Huntsman Cancer Institute, University of Utah


Manish is an Oncologist with 23 years of experience who focusses on merging biotechnology fields that involve bio-engineering, devices, AI-based algorithms with cancer genomics and other “omic” platforms for patient care and entrepreneurial advancement. In order to have successful application of this type of “convergence sciences” He also build teams that focus on health economics and outcome research (HEOR) to derive the value of merging cancer omics with AI and/or bio-engineering devices for practicing precision medicine. His roles have ranged from leading as Director of Personalized Medicine Institutes to conducting individualized medicine clinical trials. He also holds several AI-based patents.


Laura Dillon
Laura Dillon
Head of Translational Biomarkers,
Parthenon Therapeutics